Fenoterol - CAS 13392-18-2
Catalog number:
13392-18-2
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C17H21NO4
Molecular Weight:
303.36
COA:
Inquire
Targets:
Adrenergic Receptor
Description:
Fenoterol, a phenol derivative, is a β2-adrenoceptor agonist and could be used as a bronchodilator and an antiasthmatic.
Publictions citing BOC Sciences Products
  • >> More
Purity:
95%
Appearance:
Powder
Synonyms:
1-(p-hydroxyphenyl)-2-((beta-hydroxy-beta-(3’,5’-dihydroxyphenyl))ethyl)amin;1,3-benzenediol,5-(1-hydroxy-2-((2-(4-hydroxyphenyl)-1-methylethyl)amino)eth;3,5-dihydroxy-alpha-(((p-hydroxy-alpha-methylphenethyl)amino)methyl)benzyla;benzylalcohol,3,5-dihydr
Solubility:
10 mM in H2O
Storage:
-20ºC Freeze
MSDS:
Inquire
Application:
Fenoterol is a β2-adrenoceptor agonist and could be used as a bronchodilator and an antiasthmatic.
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Grams-Kilos
Boiling Point:
566ºC at 760mmHg
Melting Point:
181-183ºC
Density:
1.289 g/cm3
InChIKey:
LSLYOANBFKQKPT-UHFFFAOYSA-N
InChI:
InChI=1S/C17H21NO4/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9-16(21)8-13/h2-5,7-9,11,17-22H,6,10H2,1H3
Canonical SMILES:
CC(CC1=CC=C(C=C1)O)NCC(C2=CC(=CC(=C2)O)O)O
1.Have we achieved progress in tocolytic treatment?--results of a retrospective cohort study in a tertiary university hospital.
Tomczyk K, Rzymski P, Wilczak M. Ginekol Pol. 2015 Jul;86(7):504-8.
OBJECTIVES: Beta-agonists play an important role in tocolytic treatment. In light of recent changes in the Polish medical care system, we decided to assess the effectiveness of oral continuous treatment (in 2012) and compare it with a 3-day intravenous administration of fenoterol (in 2013). The aim of our study was to contrast cost and effectiveness of fenoterol therapy in pregnant women at risk of preterm labor during two consecutive years: 2012 - when fenoterol had been widely used (group A), and 2013 when its extensive use had been withdrawn (group B).
2.
3.β Adrenergic Receptor Kinase C-Terminal Peptide Gene-Therapy Improves β2-Adrenergic Receptor-Dependent Neoangiogenesis after Hindlimb Ischemia.
Cannavo A1, Liccardo D1, Lymperopoulos A1, Gambino G1, D'Amico ML1, Rengo F1, Koch WJ1, Leosco D2, Ferrara N1, Rengo G1. J Pharmacol Exp Ther. 2016 Feb;356(2):503-13. doi: 10.1124/jpet.115.228411. Epub 2015 Nov 24.
After hindlimb ischemia (HI), increased catecholamine levels within the ischemic muscle can cause dysregulation of β2-adrenergic receptor (β2AR) signaling, leading to reduced revascularization. Indeed, in vivo β2AR overexpression via gene therapy enhances angiogenesis in a rat model of HI. G protein-coupled receptor kinase 2 (GRK2) is a key regulator of βAR signaling, and β adrenergic receptor kinase C-terminal peptide (βARKct), a peptide inhibitor of GRK2, has been shown to prevent βAR down-regulation and to protect cardiac myocytes and stem cells from ischemic injury through restoration of β2AR protective signaling (i.e., protein kinase B/endothelial nitric oxide synthase). Herein, we tested the potential therapeutic effects of adenoviral-mediated βARKct gene transfer in an experimental model of HI and its effects on βAR signaling and on endothelial cell (EC) function in vitro. Accordingly, in this study, we surgically induced HI in rats by femoral artery resection (FAR).
4.Bone morphogenetic protein receptor type II deficiency and increased inflammatory cytokine production. A gateway to pulmonary arterial hypertension.
Soon E1,2, Crosby A1, Southwood M2, Yang P1, Tajsic T1,3, Toshner M1, Appleby S1, Shanahan CM3, Bloch KD4, Pepke-Zaba J2, Upton P1, Morrell NW1. Am J Respir Crit Care Med. 2015 Oct 1;192(7):859-72. doi: 10.1164/rccm.201408-1509OC.
RATIONALE: Mutations in bone morphogenetic protein receptor type II (BMPR-II) underlie most cases of heritable pulmonary arterial hypertension (PAH). However, disease penetrance is only 20-30%, suggesting a requirement for additional triggers. Inflammation is emerging as a key disease-related factor in PAH, but to date there is no clear mechanism linking BMPR-II deficiency and inflammation.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Adrenergic Receptor Products


Fenoterol hydrochloride
(CAS: 1944-10-1)

Fenoterol hydrochloride is a β2 adrenoreceptor agonist used as a bronchodilator for the treatment and prophylaxis of reversible bronchospasm, administered by in...

CAS 63659-18-7 Betaxolol

Betaxolol
(CAS: 63659-18-7)

Betaxolol is a selective beta1 adrenergic receptor blocker used in the treatment of hypertension and glaucoma.

CAS 13523-86-9 Pindolol

Pindolol
(CAS: 13523-86-9)

Pindolol, an Indole derivative, could be used in the treatment of hypertension and arrhythmia for acting as a 5-HT1A/1B receptor antagonist. IC50: 33nM(Ki).

CAS 67339-62-2 ARC239 dihydrochloride

ARC239 dihydrochloride
(CAS: 67339-62-2)

ARC239 dihydrochloride is a potent and selective α2 B adrenoceptor antagonist. It is used as an α-adrenoceptor blocking drug. It competitively antagonizes press...

CAS 76631-46-4 Detomidine

Detomidine
(CAS: 76631-46-4)

Detomidine is an imidazole derivative and a α2-adrenergic agonist. It is usually used in the form of detomidine hydrochloride. It is used as a large animal seda...

CAS 13392-18-2 Fenoterol

Fenoterol
(CAS: 13392-18-2)

Fenoterol, a phenol derivative, is a β2-adrenoceptor agonist and could be used as a bronchodilator and an antiasthmatic.

CAS 226081-74-9 AR-​08

AR-​08
(CAS: 226081-74-9)

AR-​08 is an agonist of α2-adrenergic receptor undergone in phase II clinical trials by Arbor Pharmaceuticals for the treatment of attention deficit and hyperac...

CAS 51384-51-1 Metoprolol

Metoprolol
(CAS: 51384-51-1)

Metoprolol is a a selective β1 receptor blocker for the treatment of a variety of cardiovascular disorder.

CAS 4205-91-8 Clonidine Hydrochloride

Clonidine Hydrochloride
(CAS: 4205-91-8)

Clonidine HCl is a direct-acting α2 adrenergic agonist with an ED50 of 0.02±0.01 mg/kg.

CAS 503068-34-6 Vilanterol

Vilanterol
(CAS: 503068-34-6)

Vilanterol (GW642444; GW 642444X) is a novel, inhaled, long-acting β(2) agonist with inherent 24-h activity under development as a once-daily combination therap...

CAS 74191-85-8 Doxazosin

Doxazosin
(CAS: 74191-85-8)

Doxazosin is a quinazoline-derivative and long-lasting α1 adrenergic receptor blocker. It inhibits the binding of norepinephrine, which is released from sympath...

CAS 847829-38-3 Rezatomidine

Rezatomidine
(CAS: 847829-38-3)

Rezatomidine is a selective α2-adrenoreceptor antagonist under the development of Allergan. No recent development was reported for the treatment of Diabetic neu...

CAS 51022-70-9 Salbutamol Sulfate

Salbutamol Sulfate
(CAS: 51022-70-9)

Salbutamol Sulfate is a Non-selective 2-adrenergic receptor agonist (IC50=8.93 µM)

CAS 89365-50-4 Salmeterol

Salmeterol
(CAS: 89365-50-4)

Salmeterol is a long-acting beta2-adrenergic receptor (beta 2AR) agonist. It is used clinically in the maintenance and prevention of asthma symptoms and mainten...

CAS 34381-68-5 Acebutolol hydrochloride

Acebutolol hydrochloride
(CAS: 34381-68-5)

Acebutolol is a β-adrenergic receptors antagonist used in the treatment of hypertension, angina pectoris and cardiac arrhythmias.

CAS 32780-64-6 labetalol hydrochloride

labetalol hydrochloride
(CAS: 32780-64-6)

Labetalol HCl is a dual antagonist for both selective alpha1-adrenergic and nonselective beta-adrenergic receptors, used in the treatment of high blood pressure...

CAS 29110-47-2 Guanfacine

Guanfacine
(CAS: 29110-47-2)

Guanfacine, a selective agonist of α2A receptor, is a sympatholytic drug to treat attention deficit hyperactivity disorder (ADHD) and hypertension. It lowers bo...

CAS 81403-68-1 Alfuzosin HCl

Alfuzosin HCl
(CAS: 81403-68-1)

Alfuzosin HCl is an alpha1 receptor antagonist used to treat benign prostatic hyperplasia (BPH).

CAS 104054-27-5 Atipamezole

Atipamezole
(CAS: 104054-27-5)

Atipamezole, a 4-substituted imidazole derivative, is an alpha2-adrenoceptor blocker which could be used for animals to recover from the anesthesia by lowering ...

CAS 29122-68-7 Atenolol

Atenolol
(CAS: 29122-68-7)

Atenolol, with antianginal and antiarrhythmic properties, it is a cardioselective beta-adrenergic blocker and used in hypertension control.

Chemical Structure

CAS 13392-18-2 Fenoterol

Quick Inquiry

Verification code

Featured Items